Company news

Immuron Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives

November 10, 2026

Immuron Engages LifeSci Capital

November 10, 2026

Emerging Growth Conference Presentation

October 28, 2026

Immuron Updates At-The-Market Funding Facility

October 26, 2026

Immuron FY27 Sales Update

October 26, 2026

CEO to present at Emerging Growth Conference

October 21, 2026

Notice of Annual General Meeting and Proxy Form

October 15, 2026

Travelan Phase 2 Study Results Published

October 12, 2026

Change in substantial holding

September 30, 2026

Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)

September 24, 2026

Appendix 4G and Corporate Governance Statement

September 24, 2026

Annual Report

September 24, 2026

Presentation to Coffee Microcaps Conference

September 21, 2026

Immuron to launch PROIBS® in the United States

September 4, 2026

PROIBS US Distribution Agreement

September 3, 2026

Immuron Reports FY26 Preliminary Results

August 28, 2026

FY26 Results Presentation

August 27, 2026

Appendix 4E Preliminary Final Report

August 27, 2026

Emerging Growth Conference Presentation

August 18, 2026

Emerging Growth Conference

August 12, 2026

IMC Rare Earths Ltd Announces Closing of $20 Million Initial Public Offering

July 30, 2026

Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar

July 20, 2026

Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

July 16, 2026

Immuron FY26 Sales Update

July 15, 2026

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

July 6, 2026

Immuron Double Digit 3Q Sales Growth

April 17, 2026

Immuron CEO, Steven Lydeamore presentation at Coffee Microcaps Conference

March 5, 2026

Strategic Update and HY26 Results

February 25, 2026

Immuron Reports HY26 Results and Strategic Reset

February 25, 2026

Appendix 4D and Half Year Report

February 25, 2026

Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream

January 21, 2026

Immuron Reports Continued Sales Growth

January 19, 2026

Uniformed Services University to Release Topline Data

December 9, 2025

Immuron New U.S. Department of Defense Award & Clinical Trial Update

December 3, 2025

Immuron IMM-529 IND approved by FDA

November 5, 2025

IMM-529 IND approved by FDA

November 5, 2025

Immuron Announces Clinical Trial Update

October 31, 2025

Clinical Trial Update

October 30, 2025

Immuron launch PROIBS for IBS

October 23, 2025

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

October 21, 2025

Immuron Q1 FY26 YoY growth

October 13, 2025

Immuron Submits IMM-529 IND to FDA

October 8, 2025

Immuron Letter to Shareholders – Projects Update

October 2, 2025

FY25 Results Presentation

August 28, 2025

Appendix 4E Preliminary Final Report

August 28, 2025

Immuron partners with InvestorHub

August 26, 2025

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

August 20, 2025

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

August 19, 2025

Immuron - FY25 global sales exceed projection, up 49% on prior year

July 17, 2025

FY25 global sales exceed projection, up 49% on prior year

July 16, 2025

Older news releases →

Decks

The 5 newest of 110 decks. Every deck is listed under its year.